Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Age-associated metabolic regulation of anti-tumor immunity
EF 2022-23
Résumé
The human population is aging at an unprecedented rate. Although aging is the most well-known risk factor for the development of cancer, pre-clinical models of immuno-oncology predominantly rely on immunocompetent young hosts which fundamentally differ from the biology of aged hosts. Thus, there is an urgent need to elucidate the mechanisms by which aging alters anti-tumor immune responses, with implications for responsiveness to cancer immunotherapy. CD8+ T cells play a central role in augmenting anti-tumor immune responses; however, these cells are highly susceptible to changes with age. In our preliminary studies, we demonstrated the accumulation of unique and dysfunctional CD8+ T cells in the tumor of aged mice. Furthermore, we provided evidence suggesting that metabolic program of the T cells may be altered in the aged setting. This proposal will test the hypothesis that metabolic deficits in aged CD8+ T cells result in attenuated anti-tumor T cell immunity and that its manipulation will improve anti-tumor immunity in aged hosts. We will test this hypothesis by first defining the unique population of dysfunctional CD8+ T cells in the tumor of aged mice. We will then interrogate how age-associated metabolic deficits in T cells could drive the accumulation of dysfunctional CD8+ T cells in the tumor, and therapeutically target the mechanism to improve responsiveness to immunotherapy in aged mice. This proposal will provide insights into the age-associated metabolic regulation of anti-tumor immunity and contribute to the development of rational cancer therapies for the elderly.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
471340
Name
Han Seong Jun
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Age-associated metabolic regulation of anti-tumor immunity
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Aging; Cancer Immunotherapy; Immune Regulation; Immune-Metabolism; T Cells
Abstract
The human population is aging at an unprecedented rate. Although aging is the most well-known risk factor for the development of cancer, pre-clinical models of immuno-oncology predominantly rely on immunocompetent young hosts which fundamentally differ from the biology of aged hosts. Thus, there is an urgent need to elucidate the mechanisms by which aging alters anti-tumor immune responses, with implications for responsiveness to cancer immunotherapy. CD8+ T cells play a central role in augmenting anti-tumor immune responses; however, these cells are highly susceptible to changes with age. In our preliminary studies, we demonstrated the accumulation of unique and dysfunctional CD8+ T cells in the tumor of aged mice. Furthermore, we provided evidence suggesting that metabolic program of the T cells may be altered in the aged setting. This proposal will test the hypothesis that metabolic deficits in aged CD8+ T cells result in attenuated anti-tumor T cell immunity and that its manipulation will improve anti-tumor immunity in aged hosts. We will test this hypothesis by first defining the unique population of dysfunctional CD8+ T cells in the tumor of aged mice. We will then interrogate how age-associated metabolic deficits in T cells could drive the accumulation of dysfunctional CD8+ T cells in the tumor, and therapeutically target the mechanism to improve responsiveness to immunotherapy in aged mice. This proposal will provide insights into the age-associated metabolic regulation of anti-tumor immunity and contribute to the development of rational cancer therapies for the elderly.
Competitiondate
202209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Han, Seong Jun
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~